systems are bracing for a surge in COVID-19 patients seeking medical care. Illness severity can range from mild to critical. 1 Those with severe disease require hospitalization for management of complications from COVID-19. Overburdened hospitals are ill equipped to handle such a surge.
Consequently, numerous jurisdictions are establishing alternate care sites either for COVID-19 patients or for treating non-COVID-19 patients. In addition, isolation and/or quarantine sites are being established so that COVID-19 patients can remain for the duration of their isolation or those exposed to the virus for a quarantine period. Whatever the name or format of such alternative care facilities, pharmaceutical services are essential. Pharmacists and other pharmacy staff have critical roles in reducing the burden and suffering from COVID-19. 2 Ensuring a reliable supply of quality-assured essential medicines and other necessary material and equipment to meet patients' needs is just the beginning. 3 Further, pharmacists have demonstrated the importance of their roles as key partners to public health agencies by dispensing critical drugs and other medical products, providing patient care services, administering vaccines, and providing information to the public during pandemics and other emergencies. 4, 5 In this issue, Hua et al. describe pharmaceutical services in a large module hospital, i.e., an alternative care site, in Wuhan, China, for treating persons with COVID-19. 6 The Jianghan module hospital was quickly constructed at the Wuhan Convention and Exhibition Center with 1,564 beds to receive patients Federation have issued guidance on preventive measures for pharmacy staff during COVID-19. 8, 9 Another limitation is the general lack of reported metrics of both the process and outcomes of pharmacy staff-provided care for patients with COVID-19 treated in this alternative care site. The intent of their particular module hospital was provision of care for COVID-19 patients with mild symptoms.
More information about staffing patterns for the provision of pharmaceutical services in this alternative care setting would have been useful. Staff shortages during responses to emergencies are commonplace. It is important to recognize and address potential barriers to surge capacity staffing during public health emergencies. 10 Despite these few limitations, this paper provides the health care and the public health community with information that may be helpful when planning for medication- 
